Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevent milk production (lactation) Age: Adult |
Dose: Oral Tablet – 1 mg (two 0.5 mg tablets) Frequency: single dose Duration: 1st day postpartum |
|
Indication: Suppression of lactation Age: Adult |
Dose: Oral Tablet – 250 mcg (one half of 0.5 mg tablet) Frequency: every 12 hours Duration: 2 days |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child Condition: No approved pediatric dosage available |
Dose: Not applicable – Not applicable Note: No approved pediatric dosage available |
Administration
- Take with food
- Take at bedtime to minimize dizziness
Side Effect
- Nausea (27%)
- Headache (26%)
- Dizziness (15%)
- Constipation (10%)
- Asthenia (9%)
- Fatigue (7%)
- Abdominal pain (5%)
- Somnolence (5%)
- Postural hypotension (4%)
- Depression (3%)
- Dyspepsia (2%)
- Nervousness (2%)
- Abnormal vision (1%)
- Breast pain (1%)
- Dysmenorrhea (1%)
- Hot flashes (1%)
- Paresthesia (1%)
- Risk of serotinin syndrome with sibutramine, avoid combination
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Antihypertensive (Captopril, Enalapril, Lisinopril, Ramipril, Benazepril, Fosinopril, Quinapril, Perindopril, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, Propranolol, Metoprolol, Atenolol, Carvedilol, Bisoprolol, Nadolol, Amlodipine, Diltiazem, Verapamil, Nifedipine, Nicardipine, Hydrochlorothiazide, Chlorthalidone, Indapamide, Furosemide, Bumetanide, Torsemide, Spironolactone, Amiloride, Triamterene, Prazosin, Doxazosin, Terazosin, Clonidine, Methyldopa, Hydralazine, Minoxidil)
|
Increased risk of orthostatic hypotension
|
|
Dopamine
|
May increase vasoconstriction effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Uncontrolled Hypertension
|
Can worsen blood pressure
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 25° C. Keep away from light, moisture & out of reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.